Characterization of Mutational Tolerance of a Viral RNA-Protein Interaction.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
25 05 2019
Historique:
received: 26 03 2019
revised: 20 05 2019
accepted: 22 05 2019
entrez: 28 5 2019
pubmed: 28 5 2019
medline: 28 7 2020
Statut: epublish

Résumé

Replication of RNA viruses is generally markedly error-prone. Nevertheless, these viruses usually retain their identity under more or less constant conditions due to different mechanisms of mutation tolerance. However, there exists only limited information on quantitative aspects of the mutational tolerance of distinct viral functions. To address this problem, we used here as a model the interaction between a replicative

Identifiants

pubmed: 31130655
pii: v11050479
doi: 10.3390/v11050479
pmc: PMC6563195
pii:
doi:

Substances chimiques

RNA, Viral 0
RNA-Binding Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11000-7
pubmed: 10500114
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13910-3
pubmed: 10570172
EMBO J. 2001 Mar 15;20(6):1439-48
pubmed: 11250909
J Virol. 2001 Nov;75(22):10696-708
pubmed: 11602711
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7289-94
pubmed: 12754380
Cell. 1992 Jan 10;68(1):119-31
pubmed: 1310072
J Virol. 1992 Oct;66(10):6028-34
pubmed: 1326654
Virus Res. 2005 Feb;107(2):141-9
pubmed: 15649560
Curr Top Microbiol Immunol. 2006;299:141-70
pubmed: 16568898
Virol J. 2007 May 24;4:44
pubmed: 17524144
Nat Med. 2008 Feb;14(2):154-61
pubmed: 18246077
J Mol Biol. 2008 May 2;378(3):749-58
pubmed: 18377931
PLoS Pathog. 2010 Jun 03;6(6):e1000936
pubmed: 20532207
J Virol. 2010 Oct;84(19):9733-48
pubmed: 20660197
J Virol. 1990 Feb;64(2):607-12
pubmed: 2153227
Cell. 1990 Oct 19;63(2):369-80
pubmed: 2170027
Nature. 2014 Jan 30;505(7485):686-90
pubmed: 24284629
J Virol. 2014 May;88(10):5803-15
pubmed: 24623423
Virology. 2015 May;479-480:46-51
pubmed: 25824477
RNA Biol. 2015;12(12):1338-54
pubmed: 26488412
Curr Top Microbiol Immunol. 2016;392:303-22
pubmed: 26499340
Annu Rev Virol. 2015 Nov;2(1):161-79
pubmed: 26958911
J Biol Chem. 2016 Jul 1;291(27):13999-4011
pubmed: 27137934
Enzymes. 2016;39:293-323
pubmed: 27241934
J Biol Chem. 2017 Mar 3;292(9):3810-3826
pubmed: 28100782
Virus Res. 2017 Apr 15;234:4-20
pubmed: 28163093
J Virol. 1988 Feb;62(2):558-62
pubmed: 2826815
Virology. 1988 Jul;165(1):42-50
pubmed: 2838971
Protein Sci. 2018 Jan;27(1):112-128
pubmed: 28836357
PeerJ. 2017 Oct 6;5:e3896
pubmed: 29018627
Eur Biophys J. 2018 May;47(4):443-457
pubmed: 29397419
Microbiol Mol Biol Rev. 2018 Mar 14;82(2):
pubmed: 29540453
J Virol. 1995 Jun;69(6):3658-67
pubmed: 7745714
J Biol Chem. 1994 Oct 28;269(43):27004-14
pubmed: 7929441
EMBO J. 1993 Sep;12(9):3587-98
pubmed: 8253083
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
RNA. 1997 Oct;3(10):1124-34
pubmed: 9326487
Annu Rev Microbiol. 1997;51:151-78
pubmed: 9343347
J Mol Biol. 1997 Nov 14;273(5):1032-47
pubmed: 9367789
RNA. 1998 Feb;4(2):215-25
pubmed: 9570321
Genes Dev. 1998 Aug 1;12(15):2293-304
pubmed: 9694795

Auteurs

Maria A Prostova (MA)

Institute of Poliomyelitis, M. P. Chumakov Center for Research and Development of Immunobiological Products, Russian Academy of Sciences, 108819 Moscow, Russia. prostovna@gmail.com.
Institute of Molecular Genetics, Russian Academy of Sciences, 123182 Moscow, Russia. prostovna@gmail.com.

Elena Smertina (E)

Institute of Poliomyelitis, M. P. Chumakov Center for Research and Development of Immunobiological Products, Russian Academy of Sciences, 108819 Moscow, Russia. l-smertina@mail.ru.
Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University, 117192 Moscow, Russia. l-smertina@mail.ru.

Denis V Bakhmutov (DV)

Institute of Poliomyelitis, M. P. Chumakov Center for Research and Development of Immunobiological Products, Russian Academy of Sciences, 108819 Moscow, Russia. labagola@mail.ru.

Anna A Gasparyan (AA)

Institute of Poliomyelitis, M. P. Chumakov Center for Research and Development of Immunobiological Products, Russian Academy of Sciences, 108819 Moscow, Russia. g.anna07@mail.ru.
Faculty of Biology, M. V. Lomonosov Moscow State University, 119991 Moscow, Russia. g.anna07@mail.ru.

Elena V Khitrina (EV)

Institute of Poliomyelitis, M. P. Chumakov Center for Research and Development of Immunobiological Products, Russian Academy of Sciences, 108819 Moscow, Russia. khitrina62@mail.ru.
A. N. Belozersky Institute of Physical-Chemical Biology, M. V. Lomonosov Moscow State University, 119899 Moscow, Russia. khitrina62@mail.ru.

Marina S Kolesnikova (MS)

Institute of Poliomyelitis, M. P. Chumakov Center for Research and Development of Immunobiological Products, Russian Academy of Sciences, 108819 Moscow, Russia. bakhmutov@mail.ru.

Anna A Shishova (AA)

Institute of Poliomyelitis, M. P. Chumakov Center for Research and Development of Immunobiological Products, Russian Academy of Sciences, 108819 Moscow, Russia. a_shishova@list.ru.

Anatoly P Gmyl (AP)

Institute of Poliomyelitis, M. P. Chumakov Center for Research and Development of Immunobiological Products, Russian Academy of Sciences, 108819 Moscow, Russia. apgmyl@mail.ru.
Faculty of Biology, M. V. Lomonosov Moscow State University, 119991 Moscow, Russia. apgmyl@mail.ru.
Sechenov First Moscow State Medical University, 119991 Moscow, Russia. apgmyl@mail.ru.

Vadim I Agol (VI)

Institute of Poliomyelitis, M. P. Chumakov Center for Research and Development of Immunobiological Products, Russian Academy of Sciences, 108819 Moscow, Russia. agol@belozersky.msu.ru.
A. N. Belozersky Institute of Physical-Chemical Biology, M. V. Lomonosov Moscow State University, 119899 Moscow, Russia. agol@belozersky.msu.ru.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH